View |
|
DRP-13578-03
|
Moxifloxacin (as hydrochloride)
|
Moxidin
|
5 mg/mL (0.5% w/v)
|
Ophthalmic Solution
|
Antiinfective (Fluoroquinolone)
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
24 June 2024
|
13 March 2028
|
View |
|
DRP-13606-01
|
Tobramycin (as sulfate)
|
Aguatob
|
3 mg/mL (0.3% w/v)
|
Ophthalmic Solution (Drops)
|
Antibacterial (Aminoglycoside)
|
Scott-Edil Pharmacia Limited
|
India
|
CLIDP Conversion
|
24 June 2024
|
16 March 2028
|
View |
|
DRP-13685-02
|
Ceftriaxone (as sodium)
|
Retactrim
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Reyoung Pharmaceutical Co. Ltd.
|
China
|
CLIDP Conversion
|
24 June 2024
|
28 March 2028
|
View |
|
DRP-13727-02
|
Rosuvastatin (as calcium)
|
Mayrosu
|
10 mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
24 June 2024
|
04 April 2028
|
View |
|
DRP-13800-02
|
Co-Amoxiclav
|
Clavulife 125
|
156.25 mg/5mL
|
Powder for Oral Suspension (Orange Flavor)
|
Antibacterial (Penicillin + Beta-Lactamase Inhibitor)
|
Yeluri Formulations Pvt Ltd.
|
India
|
CLIDP Conversion
|
29 June 2024
|
22 November 2027
|
View |
|
DRP-13833-03
|
Apixaban
|
Mediqax 2.5
|
2.5 mg
|
Film-Coated Tablet
|
Antithrombotic agent (Direct factor Xa inhibitor)
|
Unison Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
24 June 2024
|
26 April 2028
|
View |
|
DRP-13933-02
|
Clopidogrel (as bisulfate)
|
Colife
|
75 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Platelet Aggregation Inhibitor)
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
18 June 2024
|
18 May 2028
|
View |
|
DRP-14013-03
|
Atorvastatin (As Calcium)
|
Toravas
|
40 mg
|
Film-Coated Tablet
|
Lipid Modifying Agent (HMG CoA Reductase Inhibitor)
|
Hebei Tiancheng Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
19 June 2024
|
06 June 2028
|
View |
|
DRP-14019-04
|
Co-Amoxiclav
|
Retaclav-R
|
457 mg / 5 mL
|
Powder for Suspension
|
Antibacterial (Penicillin)
|
Indchemie Health Specialities Private Limited
|
India
|
CLIDP Conversion
|
18 June 2024
|
06 June 2028
|
View |
|
DRP-14214-01
|
Dexketoprofen (as trometamol)
|
Elpidex
|
25 mg / mL
|
Solution for Injection (IM/IV)
|
Non-steroidal Anti-inflammatory Drug (NSAID) and Antirheumatic
|
Osel Ilac San. Ve Tic. A.S.
|
Turkey
|
CLIDP Conversion
|
16 June 2024
|
27 July 2028
|
View |
|
DRP-14299-01
|
Hydroxycarbamide
|
Hydrobloc
|
500 mg
|
Capsule
|
Other Antineoplastic Agent
|
Laboratorio Eczane Pharma S.A
|
Argentine Republic
|
CLIDP Conversion
|
24 June 2024
|
14 August 2028
|
View |
|
DRP-14374-04
|
Cilostazol
|
Pletaz
|
50 mg
|
Tablet
|
Antithrombotic Agent (Platelet aggregation inhibitor)
|
Cooper Pharma Limited
|
India
|
CLIDP Conversion
|
23 June 2024
|
30 August 2028
|
View |
|
DRP-14515-02
|
Celecoxib
|
Retacox2
|
200 mg
|
Capsule
|
Non-Steroidal Anti-inflammatory Drug (NSAID)/ Antirheumatic Drug (Coxib)
|
Pinnacle Life Science Pvt. Ltd.
|
India
|
CLIDP Conversion
|
30 June 2024
|
27 September 2028
|
View |
|
DRP-13715-01
|
Methyldopa
|
Prevadopa
|
250 mg
|
Film-Coated Tablet
|
Centrally Acting Antiadrenergic Agent
|
Novagen Healthcare Private Limited
|
India
|
CLIDP Conversion
|
24 June 2024
|
31 March 2028
|
View |
|
DRP-14595-02
|
Acetylcysteine
|
Muconov 600
|
600 mg
|
Powder for Oral Solution
|
Mucolytic
|
Saga Lifesciences Limited
|
India
|
CLIDP Conversion
|
30 June 2024
|
20 October 2028
|
View |
|
DRP-14595-03
|
Acetylcysteine
|
Retacyl 600
|
600 mg
|
Powder for Oral Solution
|
Mucolytic
|
Saga Lifesciences Limited
|
India
|
CLIDP Conversion
|
24 June 2024
|
20 October 2028
|
View |
|
DRP-14623-01
|
Solifenacin Succinate
|
Solif
|
10 mg
|
Film-Coated Tablet
|
Selective M3 Antimuscarinic Receptor Antagonist
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
30 June 2024
|
10 November 2028
|
View |
|
DRP-14783-01
|
Carboplatin
|
Carboget
|
450 mg/45 mL (10mg/mL)
|
Solution for Intravenous Infusion
|
Antineoplastic Agent
|
Venus Remedies Limited
|
Philippines
|
CLIDP Conversion
|
29 June 2024
|
04 January 2029
|
View |
|
DR-XY49114
|
Hydrocortisone (as sodium succinate)
|
Succicort
|
100 mg
|
Powder for Solution for Injection (IM/IV)
|
Corticosteroid
|
VHB Medi Sciences Limited
|
India
|
Initial
|
27 June 2024
|
27 June 2029
|
View |
|
DRP-15364
|
Multivitamins
|
Xtravit
|
Formulation:
Each Film-Coated Tablet contains:
Ascorbic Acid (Vitamin C)
500 mg
Thiamine Mononitrate (Vitamin B1)
50 mg
Nicotinamide (Vitamin B3)
50 mg
Riboflavin (Vitamin B2)
20 mg
Calcium Pantothenate (Vitamin Bs)
20 mg
Pyridoxine Hydrochloride (Vitamin B6) 5 mg Cyanocobalamin (Vitamin B12) 5 mcg
|
Film-Coated Tablet
|
Vitamins
|
Azarias Pharmaceutical Laboratories, Inc.
|
Philippines
|
Initial
|
06 August 2024
|
07 August 2029
|